Log in to save to my catalogue

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving a...

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6997882

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?

About this item

Full title

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2020-02, Vol.38 (6), p.1277-1279

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

[...]the previously published analysis showed that: (1) all three vaccines were likely cost-effective compared to no vaccination, (2) ROTARIX was the least costly and most cost-effective product in the three examined Gavi-supported countries, and (3) the results were consistent but sensitive to small changes in input values, in particular where the...

Alternative Titles

Full title

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6997882

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6997882

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2019.12.014

How to access this item